Years ago another company was in virtually the sam
Post# of 148248
(Total Views: 577)
Posted On: 05/23/2021 5:36:17 PM
Years ago another company was in virtually the same position as CYDY is in now.
Hemispherx (HEB) had a drug, Ampligen, in clinical trial for Chronic Fatigue Syndrome. We now think that CFS is a post-viral syndrome like Long Haulers for COVID -- but at the time, no one knew what it was. There still is not a good blood test to determine if someone has CFS or some other condition. Therefore, some patients in a clinical trial may not have CFS, so a CFS-aimed drug will probably not help them.
Nevertheless, Ampligen helped about 40% of the people in the clinical trial. There was no drug approved for CFS. The FDA held 2 days of public hearings, in which patients traveled hundreds of miles to testify. The most common statement was "It gave me my life back." The stories of these patients were heart-rending.
The FDA, of course, did NOT approve the drug, despite its 40% efficacy.
Why, you ask? Because the CEO of HEB was widely viewed as an arrogant self-serving con man, who had offended many of the people on the review board.
"I'm going to go look at a chart of HEB," you cry. But wait -- there is no chart, why is that?
Because HEB no longer exists. They got rid of the CEO, restructured, changed their name.
"AIM" now owns Ampligen. It's still not approved.
There is STILL no approved treatment for CFS. Some people with resources are able to get it from some Canadian doctor.
So -- do you really think that it's a good idea to make the FDA even madder? If you think that public opinion is going to force them into approving a drug, think again.
Hemispherx (HEB) had a drug, Ampligen, in clinical trial for Chronic Fatigue Syndrome. We now think that CFS is a post-viral syndrome like Long Haulers for COVID -- but at the time, no one knew what it was. There still is not a good blood test to determine if someone has CFS or some other condition. Therefore, some patients in a clinical trial may not have CFS, so a CFS-aimed drug will probably not help them.
Nevertheless, Ampligen helped about 40% of the people in the clinical trial. There was no drug approved for CFS. The FDA held 2 days of public hearings, in which patients traveled hundreds of miles to testify. The most common statement was "It gave me my life back." The stories of these patients were heart-rending.
The FDA, of course, did NOT approve the drug, despite its 40% efficacy.
Why, you ask? Because the CEO of HEB was widely viewed as an arrogant self-serving con man, who had offended many of the people on the review board.
"I'm going to go look at a chart of HEB," you cry. But wait -- there is no chart, why is that?
Because HEB no longer exists. They got rid of the CEO, restructured, changed their name.
"AIM" now owns Ampligen. It's still not approved.
There is STILL no approved treatment for CFS. Some people with resources are able to get it from some Canadian doctor.
So -- do you really think that it's a good idea to make the FDA even madder? If you think that public opinion is going to force them into approving a drug, think again.
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼